NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

CUSIP: 64125C109

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock
Shares outstanding
99,963,154
Total 13F shares
93,003,458
Share change
-809,186
Total reported value
$10,720,376,398
Put/Call ratio
93%
Price per share
$115.22
Number of holders
570
Value change
-$150,384,737
Number of buys
294
Number of sells
284

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
14%
14,190,708
$1,953,634,771 30 Jun 2024
13F
VANGUARD GROUP INC
13F
Company
10%
10,056,446
$1,384,470,920 30 Jun 2024
13F
STATE STREET CORP
13F
Company
4.6%
4,608,357
$634,432,508 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.5%
2,468,146
$339,789,660 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
2.4%
2,362,735
$325,277,821 30 Jun 2024
13F
Bellevue Group AG
13F
Company
1.9%
1,898,640
$261,385,769 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
1,819,622
$250,114,049 30 Jun 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.8%
1,798,848
$247,649,000 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
1.5%
1,544,869
$212,682,418 30 Jun 2024
13F
DODGE & COX
13F
Company
1.3%
1,280,820
$176,330,489 30 Jun 2024
13F
Invesco Ltd.
13F
Company
1.3%
1,258,104
$173,203,180 30 Jun 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.2%
1,223,055
$166,959,238 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
1,132,589
$155,923,578 30 Jun 2024
13F
DSM CAPITAL PARTNERS LLC
13F
Company
1%
997,784
$137,364,923 30 Jun 2024
13F
BROWN ADVISORY INC
13F
Company
1%
995,214
$137,011,112 30 Jun 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.98%
978,488
$134,708,443 30 Jun 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.97%
971,203
$133,705,409 30 Jun 2024
13F
Rock Springs Capital Management LP
13F
Company
0.94%
940,000
$129,409,800 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.93%
934,404
$128,639,426 30 Jun 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.91%
912,064
$125,563,850 30 Jun 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.9%
899,493
$123,833,201 30 Jun 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.87%
871,324
$119,955,175 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.81%
810,620
$111,598,054 30 Jun 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.81%
808,450
$111,299,311 30 Jun 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.78%
782,870
$107,778,000 30 Jun 2024
13F
BRAIDWELL LP
13F
Company
0.76%
759,009
$104,492,769 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.75%
752,501
$103,596,813 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.74%
740,939
$102,005,072 30 Jun 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.72%
721,087
$99,272,047 30 Jun 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.71%
710,600
$97,828,449 30 Jun 2024
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.68%
680,034
$95,279,563 30 Jun 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.69%
691,004
$95,130,521 30 Jun 2024
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
0.66%
656,118
$90,327,767 30 Jun 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.65%
649,909
$89,472,972 30 Jun 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.62%
621,865
$85,612,155 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.62%
618,931
$85,208,234 30 Jun 2024
13F
Polar Capital Holdings Plc
13F
Company
0.61%
610,552
$84,054,694 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.6%
601,720
$82,838,793 30 Jun 2024
13F
GW&K Investment Management, LLC
13F
Company
0.55%
546,068
$75,178,000 30 Jun 2024
13F
1832 Asset Management L.P.
13F
Company
0.54%
541,200
$74,507,004 30 Jun 2024
13F
Fiera Capital Corp
13F
Company
0.53%
527,902
$72,676,269 30 Jun 2024
13F
IEQ CAPITAL, LLC
13F
Company
0.51%
506,086
$69,672,859 30 Jun 2024
13F
JENNISON ASSOCIATES LLC
13F
Company
0.5%
499,323
$68,741,798 30 Jun 2024
13F
Avidity Partners Management LP
13F
Company
0.49%
491,000
$67,595,970 30 Jun 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.49%
485,020
$66,772,703 30 Jun 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.48%
484,777
$66,739,250 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.47%
472,929
$65,096,819 30 Jun 2024
13F
S.c.a. Candriam
13F
Individual
0.47%
465,467
$64,077,852 30 Jun 2024
13F
NORGES BANK
13F
Company
0.45%
449,565
$61,891,614 30 Jun 2024
13F
ORBIMED ADVISORS LLC
13F
Company
0.45%
448,200
$61,703,694 30 Jun 2024
13F

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2024

As of 30 Sep 2024, NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by 570 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,003,458 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Bellevue Group AG, GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JPMORGAN CHASE & CO. This page lists 573 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
589
Q3 2024 holders
570
Holder diff
-19
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.